| Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer ME Taplin, GJ Bubley, TD Shuster, ME Frantz, AE Spooner, GK Ogata, ... New England Journal of Medicine 332 (21), 1393-1398, 1995 | 1615 | 1995 |
| Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer M Stanbrough, GJ Bubley, K Ross, TR Golub, MA Rubin, TM Penning, ... Cancer research 66 (5), 2815-2825, 2006 | 1354 | 2006 |
| Biology of prostate-specific antigen SP Balk, YJ Ko, GJ Bubley Journal of clinical oncology 21 (2), 383-391, 2003 | 1136 | 2003 |
| Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ... Cell 138 (2), 245-256, 2009 | 1073 | 2009 |
| EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ... Science 338 (6113), 1465-1469, 2012 | 943 | 2012 |
| Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant … S Porcelli, CE Yockey, MB Brenner, SP Balk The Journal of experimental medicine 178 (1), 1-16, 1993 | 847 | 1993 |
| Erratum: Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes SB Wilson, SC Kent, KT Patton, T Orban, RA Jackson, M Exley, S Porcelli, ... Nature 399 (6731), 84-84, 1999 | 836 | 1999 |
| Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist ME Taplin, GJ Bubley, YJ Ko, EJ Small, M Upton, B Rajeshkumar, SP Balk Cancer research 59 (11), 2511-2515, 1999 | 819 | 1999 |
| Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells M Exley, J Garcia, SP Balk, S Porcelli The Journal of experimental medicine 186 (1), 109-120, 1997 | 654 | 1997 |
| Recognition of cluster of differentiation 1 antigens by human CD4−CD8>− cytolytic T lymphocyte S Porcelli, MB Brenner, JL Greenstein, C Terhorst, SP Balk, PA Bleicher Nature 341 (6241), 447-450, 1989 | 654 | 1989 |
| Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production L Lynch, M Nowak, B Varghese, J Clark, AE Hogan, V Toxavidis, SP Balk, ... Immunity 37 (3), 574-587, 2012 | 542 | 2012 |
| CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells FM Spada, Y Koezuka, SA Porcelli The Journal of experimental medicine 188 (8), 1529-1534, 1998 | 538 | 1998 |
| Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence ME Taplin, SP Balk Journal of cellular biochemistry 91 (3), 483-190, 2004 | 501 | 2004 |
| Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 … C Cai, S Chen, P Ng, GJ Bubley, PS Nelson, EA Mostaghel, B Marck, ... Cancer research 71 (20), 6503-6513, 2011 | 500 | 2011 |
| Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1 C Cai, HH He, S Chen, I Coleman, H Wang, Z Fang, S Chen, PS Nelson, ... Cancer cell 20 (4), 457-471, 2011 | 498 | 2011 |
| Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol S Joyce, AS Woods, JW Yewdell, JR Bennink, AD De Silva, A Boesteanu, ... Science 279 (5356), 1541-1544, 1998 | 487 | 1998 |
| Her-2-neu expression and progression toward androgen independence in human prostate cancer S Signoretti, R Montironi, J Manola, A Altimari, C Tam, G Bubley, S Balk, ... Journal of the National Cancer Institute 92 (23), 1918-1925, 2000 | 479 | 2000 |
| Loss of IFN-γ production by invariant NK T cells in advanced cancer S Muhammad Ali Tahir, O Cheng, A Shaulov, Y Koezuka, GJ Bubley, ... The Journal of Immunology 167 (7), 4046-4050, 2001 | 445 | 2001 |
| AR, the cell cycle, and prostate cancer SP Balk, KE Knudsen Nuclear receptor signaling 6 (1), nrs. 06001, 2008 | 432 | 2008 |
| CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site KH Sonoda, M Exley, S Snapper, SP Balk, J Stein-Streilein The Journal of experimental medicine 190 (9), 1215-1226, 1999 | 429 | 1999 |
